L3VLUP
ProSign in

CVS in the 13F filings

CVS Health Corp · CUSIP 126650100

Sector · Consumer staples
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2025
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 5 Feb 2026
Managers listing it
39
at least, of 95 tracked, among listed positions
Comparable managers
92
filed both Q3 2025 and Q4 2025; 28 listed it in both
Shares listed
289,932,099
combined, among listed positions
Reported value
$23.0bn
combined, at the quarter end

Among the 92 comparable managers: 18 buyers (opened or added shares) and 23 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -3,453,456.

Managers listing CVS in Q4 2025

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

39 of 39 holders

ActionFiling
Capital World Investors67,662,911$5.4bn0.73%Trimmed-719,24711 Feb 2026 (the filing on sec.gov)
Dodge & Cox62,509,988$5.0bn2.68%Trimmed-10,666,59813 Feb 2026 (the filing on sec.gov)
Fidelity (FMR LLC)41,017,981$3.3bn0.17%Trimmed-2,317,28017 Feb 2026 (the filing on sec.gov)
Invesco Ltd24,019,141$1.9bn0.18%Trimmed-273,91719 Feb 2026 (the filing on sec.gov)
Wellington Management Group LLP18,564,392$1.5bn0.26%Added+12,233,67517 Feb 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc16,443,986$1.3bn0.14%Trimmed-953,74917 Feb 2026 (the filing on sec.gov)
Capital Research Global Investors12,043,423$956m0.18%Added+574,17311 Feb 2026 (the filing on sec.gov)
Glenview Capital Management LLC8,196,799$650m13.24%Held017 Feb 2026 (the filing on sec.gov)
Arrowstreet Capital LP4,319,824$343m0.20%Trimmed-974,31013 Feb 2026 (the filing on sec.gov)
Holocene Advisors LP3,968,803$315m0.66%Added+2,300,57617 Feb 2026 (the filing on sec.gov)
Janus Henderson Group Ltd3,616,946$287m0.13%Added+246,47117 Feb 2026 (the filing on sec.gov)
Citadel Advisors LLC3,601,353$286munder 0.1%Added+384,17617 Feb 2026 (the filing on sec.gov)
Millennium Management LLC3,464,096$275m0.12%Trimmed-1,914,05217 Feb 2026 (the filing on sec.gov)
AllianceBernstein LP3,309,609$263m0.08%Added+1,867,49317 Feb 2026 (the filing on sec.gov)
AQR Capital Management LLC2,614,958$208m0.11%Trimmed-437,88117 Feb 2026 (the filing on sec.gov)
Sachem Head Capital Management LP2,585,000$205m4.81%Trimmed-565,00013 Feb 2026 (the filing on sec.gov)
Point72 Asset Management LP2,088,622$166m0.19%Added+1,662,53517 Feb 2026 (the filing on sec.gov)
Susquehanna International Group LLP1,526,810$121munder 0.1%Added+445,04117 Feb 2026 (the filing on sec.gov)
Woodline Partners LP1,397,302$111m0.43%Added+695,55417 Feb 2026 (the filing on sec.gov)
Freestone Grove Partners LP1,112,239$88m0.64%Trimmed-134,08317 Feb 2026 (the filing on sec.gov)
D. E. Shaw & Co.1,074,888$85munder 0.1%Trimmed-43,25517 Feb 2026 (the filing on sec.gov)
Bridgewater Associates LP1,037,352$82m0.30%Trimmed-155,79213 Feb 2026 (the filing on sec.gov)
Balyasny Asset Management LLC938,057$74m0.09%Added+527,39317 Feb 2026 (the filing on sec.gov)
Harris Associates LP525,051$42m0.05%Trimmed-23,52117 Feb 2026 (the filing on sec.gov)
Man Group PLC454,000$36m0.06%Trimmed-169,53417 Feb 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q3 2025 to Q4 2025, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
31 in Q3 2024 to 31 in Q2 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
CVS by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201319$12.0bnn.a.n.a.
Q3 201322$11.8bnn.a.n.a.
Q4 201319$14.0bnn.a.n.a.
Q1 201417$15.3bnn.a.n.a.
Q2 201424$14.7bnn.a.n.a.
Q3 201421$15.4bnn.a.n.a.
Q4 201424$18.3bnn.a.n.a.
Q1 201525$19.7bnn.a.n.a.
Q2 201524$20.2bnn.a.n.a.
Q3 201530$19.0bnn.a.n.a.
Q4 201525$17.8bnn.a.n.a.
Q1 201624$17.1bnn.a.n.a.
Q2 201634$14.3bnn.a.n.a.
Q3 201630$12.8bnn.a.n.a.
Q4 201632$9.3bnn.a.n.a.
Q1 201729$8.7bnn.a.n.a.
Q2 201720$9.0bnn.a.n.a.
Q3 201723$9.4bnn.a.n.a.
Q4 201732$10.5bnn.a.n.a.
Q1 201831$8.7bnn.a.n.a.
Q2 201821$8.1bnn.a.n.a.
Q3 201825$10.7bnn.a.n.a.
Q4 201833$11.4bnn.a.n.a.
Q1 201927$8.5bnn.a.n.a.
Q2 201925$8.0bnn.a.n.a.
Q3 201925$9.6bnn.a.n.a.
Q4 201927$11.4bnn.a.n.a.
Q1 202029$8.1bnn.a.n.a.
Q2 202026$9.3bnn.a.n.a.
Q3 202029$8.9bnn.a.n.a.
Q4 202022$9.8bnn.a.n.a.
Q1 202128$10.3bnn.a.n.a.
Q2 202124$11.8bnn.a.n.a.
Q3 202128$11.9bnn.a.n.a.
Q4 202128$14.7bnn.a.n.a.
Q1 202225$14.4bnn.a.n.a.
Q2 202230$13.5bnn.a.n.a.
Q3 202228$13.9bnn.a.n.a.
Q4 202230$12.6bnn.a.n.a.
Q1 202336$9.6bnn.a.n.a.
Q2 202333$9.8bnn.a.n.a.
Q3 202333$11.7bnn.a.n.a.
Q4 202332$14.2bn1518
Q1 202421$14.3bn914
Q2 202424$14.2bn168
Q3 202431$14.2bn2310
Q4 202432$11.0bn1716
Q1 202529$19.1bn2010
Q2 202531$19.6bn1912
Q3 202528$21.9bn1611
Q4 202529$22.8bn1823
Q1 202632$21.1bn2420
Q2 202631$30.8bn1824

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

CVS and PM →CVS and KO →CVS and COST →Choose a stock to compare with CVS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own CVS, latest filings →Back to the 13F Explorer →